Showing results (121-130 of 313) with videos related to

Sort By:
Pageof 32
Cancer|May 14, 2008
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignanciesGautam Borthakur, Yesid Alvarado, Farhad Ravandi-Kashani, et al.
Blood|October 17, 2012
Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaAlfonso Quintás-Cardama, Farhad Ravandi, Theresa Liu-Dumlao, et al.
Cancer|January 26, 2006
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcomeHagop Kantarjian, Susan O'brien, Jorge Cortes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosisSrdan Verstovsek, Ayalew Tefferi, Jorge Cortes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2009
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndromeGloria N Mattiuzzi, Jorge Cortes, Gladys Alvarado, et al.
Cancer|December 19, 2007
Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions?Hagop Kantarjian, Susan O'Brien, Jianqin Shan, et al.
Leukemia & Lymphoma|September 1, 2011
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemiaDavid Claxton, Harry P Erba, Stefan Faderl, et al.
Cancer|October 2, 2009
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesFarhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, et al.
Haematologica|November 8, 2011
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patientsAref Al-Kali, Sergej Konoplev, Erpei Lin, et al.
Haematologica|October 19, 2010
Phase I study of sorafenib in patients with refractory or relapsed acute leukemiasGautam Borthakur, Hagop Kantarjian, Farhad Ravandi, et al.
Pageof 32